Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitorsKate F Byth, Nicola Cooper, Janet D Culshaw, et al.
European Journal of Human Genetics : EJHG|November 26, 2024
Molecular diagnoses and candidate gene identification in the congenital heart disease cohorts of the 100,000 genomes projectVerity Hartill, Mitra Kabir, Sunayna Best, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthmaGeorge M Buckley, Nicola Cooper, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthmaGeorge M Buckley, Nicola Cooper, Richard J Davenport, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitorM Motasim Billah, Nicola Cooper, Michael Minnicozzi, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
8-Methoxyquinolines as PDE4 inhibitorsMotasim Billah, George M Buckley, Nicola Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and profile of SCH351591, a novel PDE4 inhibitorMotasim Billah, Nicola Cooper, Francis Cuss, et al.
Kidney International Reports|November 13, 2024
Kidney Beam-A Cost-Effective Digital Intervention to Improve Mental HealthSharlene A Greenwood, Juliet Briggs, Christy Walklin, et al.
Pageof 9